New technique to see if cancer treatment works

10 December 2007

A cutting-edge technique that boosts the sensitivity of magnetic resonance imaging more than 10,000-fold could allow cancer patients to find out within days of starting treatment how their tumors are likely to respond, a Cancer Research UK study published in Nature Medicine has revealed.

Establishing early on whether a drug is having the desired effect on a patient's cancer - and if necessary changing to an alternative - can have considerable implications for survival. But patients' response to treatment is largely assessed by monitoring the size of their tumors over time. And even if a drug is working, it can take weeks before the tumour stops growing or begins to shrink.

Now scientists in Cambridge, UK, using a super-sensitive scanning technique, developed by GE Healthcare, have captured images of a treatment given to mice with lymphoma taking effect shortly after being administered. The significantly enhanced MRI scans allowed the researchers to observe tumor cells being killed off, confirming that the drug was working. It is hoped further research will prove the technique is also effective in cancer patients.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Companies featured in this story

More ones to watch >




Today's issue

Company Spotlight